|Application ||IHC-F, E|
|Immunogen||New York City Board of Health (NYCBOH) strain.|
|Shelf Life||18 months from date of despatch.|
|Target/Specificity||Rabbit anti-vaccinia virus antibody recognizes Vaccinia virus purified virions. It reacts with Lister and NYCBOH strains of Vaccinia.It does not cross react with Parainfluenza (1-3), RSV, Adenovirus, Influenza A+B, or HSV.|
|Preservative & Stabilisers||0.1% Sodium Azide (NaN3)|
|Storage||Store at +4℃ or at -20 ℃.|
|Precautions||Anti-Vaccinia Virus Antibody is for research use only and not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
1. Hornemann, S. et al. (2003) Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L.J. Virol. 77: 8394 - 8407. 2. Manuel, E.R. et al. (2010) Intergenic region 3 of modified vaccinia ankara is a functional site for insert gene expression and allows for potent antigen-specific immune responses.Virology. 2010 403: 155-62. 3. Staib, C. et al. (2004) Construction and isolation of recombinant MVA.Methods Mol Biol. 269: 77-100. 4. Olszewska, W. et al. (2004) Protective and disease-enhancing immune responses induced by recombinant modified vaccinia Ankara (MVA) expressing respiratory syncytial virus proteins.Vaccine. 23: 215-21. 5. Vogel, T.U. et al. (2003) Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239.J Virol. 77: 13348-60. 6. Buttigieg, K.R. et al. (2014) A Novel Vaccine against Crimean-Congo Haemorrhagic Fever Protects 100% of Animals against Lethal Challenge in a Mouse Model.PLoS One. 9(3):e91516.
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.